DTL
STRO icon

Dynamic Technology Lab’s Sutro Biopharma STRO Stock Holding History

Dynamic Technology Lab’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,431
Closed -$26K – 1338
2024
Q4 		$26K Buy
+1,431
New +$43.7K ﹤0.01% 860
2024
Q3 		– Sell
-3,131
Closed -$92K – 1337
2024
Q2 		$92K Sell
3,131
-597
-16% -$23.6K 0.01% 857
2024
Q1 		$211K Buy
3,728
+2,338
+168% +$103K 0.02% 905
2023
Q4 		$60K Buy
+1,390
New +$44.1K 0.01% 966
2021
Q3 		– Sell
-1,555
Closed -$289K – 1448
2021
Q2 		$289K Buy
+1,555
New +$304K 0.03% 804

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Dynamic Technology Lab's STRO Position: Q1 2025 in Review

Dynamic Technology Lab sold out of Sutro Biopharma (STRO) in Q1 2025, closing a stake of 1,431 shares — an estimated $26K sold.

Dynamic Technology Lab first reported a position in STRO in Q2 2021 and held it in 5 quarters. The position peaked at $289K in Q2 2021. 112 funds tracked by Wall St. Rank hold STRO as of Q1 2025.

  • Dynamic Technology Lab reported no remaining Sutro Biopharma position as of Q1 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 1,431 Sutro Biopharma shares in Q1 2025, an estimated $26K.
  • Dynamic Technology Lab first reported a position in Sutro Biopharma in Q2 2021 and held it in 5 quarters.
  • Dynamic Technology Lab's Sutro Biopharma position peaked at $289K in Q2 2021.
  • 112 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2025.

Based on Dynamic Technology Lab's 13F filing for Q1 2025, filed 16 May 2025.